Directory
>
Andrew Moin
Andrew Moin
Board Member | SAB BIO
United States
Andrew Moin
Summary
Andrew Moin is a seasoned finance professional with a strong background in investment management and analysis. Currently a Partner and Analyst at Sessa Capital, he leverages his expertise in equity derivatives and fixed income to inform investment strategies. With a law degree from Harvard and experience as a Superforecaster, Andrew combines analytical rigor with strategic foresight. His diverse career spans roles in both the pharmaceutical and legal sectors, showcasing his adaptability across industries. As a Board Member of Sab Biotherapeutics, he is involved in shaping the future of healthcare investments. Andrew is committed to continuous learning and professional development, evidenced by his extensive educational background and varied work experiences. He is known for his analytical thinking and ability to forecast market trends effectively. His passion for economics and finance drives his interest in emerging technologies and innovative investment approaches.
Andrew Moin
Work Experience
Board Member at
SAB BIO
October 2023 - Present
Partner and Analyst at
Sessa Capital
August 2012 - Present
Superforecaster at
Good Judgment Project
January 2011 - January 2015
Associate, Tax at
Sullivan & Cromwell LLP
September 2008 - July 2012
Summer Associate at
Sullivan & Cromwell LLP
May 2007 - August 2007
Research Assistant at
Amherst College Economics Department
March 2003 - May 2003
Andrew Moin
Education
Harvard Law School, J.D., Magna Cum Laude
January 2005 - January 2008
Amherst College, B.A., With Distinction
January 2001 - January 2005
South Side High School
January 1997 - January 2001
Frequently Asked Questions about Andrew Moin
What company does Andrew Moin work for?
Andrew Moin is a Board Member at SAB BIO, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Andrew Moin graduated from?
Andrew Moin holds a degree in from Harvard Law School.
Who is Andrew Moin?
Andrew Moin is a seasoned finance professional with a strong background in investment management and analysis. Currently a Partner and Analyst at Sessa Capital, he leverages his expertise in equity derivatives and fixed income to inform investment strategies. With a law degree from Harvard and experience as a Superforecaster, Andrew combines analytical rigor with strategic foresight. His diverse career spans roles in both the pharmaceutical and legal sectors, showcasing his adaptability across industries. As a Board Member of Sab Biotherapeutics, he is involved in shaping the future of healthcare investments. Andrew is committed to continuous learning and professional development, evidenced by his extensive educational background and varied work experiences. He is known for his analytical thinking and ability to forecast market trends effectively. His passion for economics and finance drives his interest in emerging technologies and innovative investment approaches.
Andrew`s contact details
Colleagues
Executive Director, Head of Quality
Chairman & CEO
Vice President, Clinical Operations
Board Member
Senior Director, Office of the President
Executive Vice President & Chief Operating Officer
Senior Vice President, Research and Product Development
Chief Medical Officer, EVP
VP of Finance